Bristol-Myers Squibb buy Piper Sandler
Start price
22.04.25
/
50%
€42.44
Target price
22.04.26
-
Performance (%)
17.24%
End price
23.04.26
€49.75
Summary
This prediction ended on 23.04.26 with a price of €49.75. The prediction had a final performance of 17.24%. Piper_Sandler has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 4.528% | 4.528% | 36.285% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Piper_Sandler for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€51.31
23.02.26
23.02.26
€63.41
23.02.27
23.02.27
8.89%
28.07.26
28.07.26
